James N. Woody - Net Worth and Insider Trading
James N. Woody Net Worth
The estimated net worth of James N. Woody is at least $2 Million dollars as of 2024-11-29. James N. Woody is the Director, 10% Owner of OncoMed Pharmaceuticals Inc and owns about 2,783,118 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $2 Million. James N. Woody is also the CEO of 180 Life Sciences Corp and owns about 3,520 shares of 180 Life Sciences Corp (ATNF) stock worth over $7,709. Details can be seen in James N. Woody's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James N. Woody has not made any transactions after 2023-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James N. Woody
James N. Woody Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James N. Woody owns 1 companies in total, including 180 Life Sciences Corp (ATNF) .
Click here to see the complete history of James N. Woody’s form 4 insider trades.
Insider Ownership Summary of James N. Woody
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATNF | 180 Life Sciences Corp | 2023-12-15 | director & Chief Executive Officer |
James N. Woody Latest Holdings Summary
James N. Woody currently owns a total of 2 stocks. Among these stocks, James N. Woody owns 2,783,118 shares of OncoMed Pharmaceuticals Inc (OMED) as of July 23, 2013, with a value of $2 Million and a weighting of 99.69%. James N. Woody also owns 3,520 shares of 180 Life Sciences Corp (ATNF) as of December 15, 2023, with a value of $7,709 and a weighting of 0.31%.
Latest Holdings of James N. Woody
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OMED | OncoMed Pharmaceuticals Inc | 2013-07-23 | 2,783,118 | 0.89 | 2,476,975 |
| ATNF | 180 Life Sciences Corp | 2023-12-15 | 3,520 | 2.19 | 7,709 |
Holding Weightings of James N. Woody
James N. Woody Form 4 Trading Tracker
According to the SEC Form 4 filings, James N. Woody has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the acquisition of 88,235 shares on July 23, 2013, which cost James N. Woody around $2 Million.
According to the SEC Form 4 filings, James N. Woody has made a total of 4 transactions in 180 Life Sciences Corp (ATNF) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in 180 Life Sciences Corp is the acquisition of 1,316 shares on December 15, 2023, which cost James N. Woody around $4,750.
Insider Trading History of James N. Woody
- 1
James N. Woody Trading Performance
GuruFocus tracks the stock performance after each of James N. Woody's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James N. Woody is -6.35%. GuruFocus also compares James N. Woody's trading performance to market benchmark return within the same time period. The performance of stocks bought by James N. Woody within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James N. Woody's insider trading performs compared to the benchmark.
Performance of James N. Woody
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.07 | | | | | |
| Relative Return to S&P 500(%) | -13.74 | | | | | |
James N. Woody Ownership Network
James N. Woody Owned Company Details
What does 180 Life Sciences Corp do?
Who are the key executives at 180 Life Sciences Corp?
James N. Woody is the director & Chief Executive Officer of 180 Life Sciences Corp. Other key executives at 180 Life Sciences Corp include COO / Chief Business Officer Quan Anh Vu , Interim CFO Ozan Pamir , and director & 10 percent owner & Chief Executive Officer Marlene Krauss .
180 Life Sciences Corp (ATNF) Insider Trades Summary
Over the past 18 months, James N. Woody made 1 insider transaction in 180 Life Sciences Corp (ATNF) with a net purchase of 25,000. Other recent insider transactions involving 180 Life Sciences Corp (ATNF) include a net sale of 25,000 shares made by Marc Feldmann , a net purchase of 18,000 shares made by Lawrence Steinman , and a net purchase of 10,000 shares made by Mcgovern Jr. Donald A. .
In summary, during the past 3 months, insiders sold 0 shares of 180 Life Sciences Corp (ATNF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,316 shares of 180 Life Sciences Corp (ATNF) were sold and 2,789 shares were bought by its insiders, resulting in a net purchase of 1,474 shares.
180 Life Sciences Corp (ATNF)'s detailed insider trading history can be found in Insider Trading Tracker table.
180 Life Sciences Corp Insider Transactions
James N. Woody Mailing Address
Above is the net worth, insider trading, and ownership report for James N. Woody. You might contact James N. Woody via mailing address: C/o Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
